GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Far East Bio Tec Co 6886.TWO · TWD

Consumer Staples · Taipei Exchange · 🇹🇼 Taiwan

Compare

38.65

0.00%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Far East Bio Tec Co

Its shares trade on Taipei Exchange under the ticker 6886.TWO. It has been listed since 27 April 2023. In the fiscal year to 31 December 2025, it reported revenue of TWD 401.7m and net income of TWD 60.0m. At that date it held total assets of TWD 702.0m and shareholders' equity of TWD 587.9m.

Far East Bio-Tec.Co., Ltd. provides biotechnology services. The company is headquartered in Taipei City, Taipei. The company went IPO on 2023-04-27. The firm's main products include health foods and biomedical reagents. The health food products include basic care series, functional care series and health protection series. The main products of biomedical reagents are fluorescent protein and recombinant protein.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
27 Apr 2023

Leadership

Pay as last reported

  • Zhuangqun QueChairman of the Board
  • Ruilin ZhangChief Information Security Officer
  • Ms. Shu'e MaiDirector
  • Mr. Shanghao ZhengDirector
  • Wanting BaiIndependent Director
  • Dengfu GuoIndependent Director
  • Yihui XuIndependent Director
  • Zhiming YanIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Far East Bio Tec Co Ltd operates in the Consumer Staples sector with a focus on consumer products.
  • The company offers health food products including the basic care series and functional care series.
  • Biomedical reagent offerings include fluorescent protein and recombinant protein for biotechnology services.

Weaknesses

  • The company is headquartered in Taipei City, limiting its physical presence to a single location.
  • Far East Bio Tec Co Ltd has a narrow product line focused primarily on health foods and biomedical reagents.
  • The firm went public in April 2023, indicating a relatively recent listing history.

Opportunities

  • Expansion of the health protection series could attract more consumers in the consumer products industry.
  • Leveraging biotechnology services may enhance the value proposition of biomedical reagents.
  • Growing demand for functional care series products presents growth potential in the Consumer Staples sector.

Threats

  • Competition within the consumer products industry may pressure margins for health food products.
  • Regulatory changes in the Consumer Staples sector could impact the distribution of biomedical reagents.
  • Economic fluctuations in Taipei City may affect consumer spending on basic care series items.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.